If you are ready to explore whether prescription support fits your profile, you can complete the free assessment quiz
These results help you and your doctor figure out if your issue is likely dietary or something more complex
McGill researchers are calling for more studies on the growing GLP-1 offerings, including if combining therapies could bring even more benefits
in 30% of the cases, the preoperative modified McCormick scale was not determinable (Table 1)
A recent study showed people who stop taking GLP-1 jabs regain all the weight they lost in under two years
These preliminary findings highlight the potential benefit of combination therapy, particularly for individuals with heightened cardiovascular risk, though validation through prospective, larger, more powerful studies is warranted